Skip to main content
Clinical Trials/NCT03884179
NCT03884179
Unknown
Not Applicable

Diagnosis of Pancreatic Cystic Lesions With EUS-FNA and Cross-sectional Imaging - A Report of Accuracy

Sahlgrenska University Hospital, Sweden0 sites58 target enrollmentFebruary 1, 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pancreatic Cyst
Sponsor
Sahlgrenska University Hospital, Sweden
Enrollment
58
Primary Endpoint
Accuracy of EUS-FNA vs Radiology
Last Updated
7 years ago

Overview

Brief Summary

Pancreatic cystic lesions (PCLs) comprise of a heterogeneous group of entities that are benign, premalignant or malignant. With increased use of modern imaging techniques in recent years, incidentally discovered PCL have become much more common. However, imaging modalities for characterising PCL is a known clinical uncertainty since imaging is capable of detecting these lesions but may often not be able to distinguish malignant from benign lesions. Incorrect assessment of PCL can lead to fatal consequences because a malignant lesion may not be treated and a benign may be unnecessarily resected. The aim of this study was to assess the performance of endoscopic ultrasound with fine-needle aspiration (EUS-FNA) in the diagnosis of pancreatic cystic lesions compared to cross-sectional imaging modalities (CT/MRI). Our hypothesis is that EUS-FNA has a higher accuracy for diagnosing PCLs compared with cross-sectional imaging.

Registry
clinicaltrials.gov
Start Date
February 1, 2007
End Date
March 1, 2020
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Sahlgrenska University Hospital, Sweden
Responsible Party
Principal Investigator
Principal Investigator

Riadh Sadik

Ass Prof

Sahlgrenska University Hospital, Sweden

Eligibility Criteria

Inclusion Criteria

  • Patients with suspected PCLs according to radiology undergoing evaluation with EUS-FNA at a tertiarry endoscopy center from February 2007 until March 2017, who underwent pancreas resection
  • Oral and written consent of patients examined

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Accuracy of EUS-FNA vs Radiology

Time Frame: 10 years

To compare the accuracy of EUS-FNA(morphology, cytology, CEA(ng/ml)) with CT/MRI in the diagnosis of pancreatic cystic lesions. Surgical pathology is used as gold standard Established CEA cut-offs of \>192 ng/ml were used for mucinous assessment and \>1000 ng/ml for established cancer assessment. A CEA value of 5 ng/ml or less was indicative of a serous cyst

Secondary Outcomes

  • Accuracy of EUS FNA vs cytology(10 years)
  • Accuracy of EUS-FNA vs morphology(10 years)
  • Accuracy of EUS FNA vs CEA(10 years)

Similar Trials